Skip to main content
Clinical Trials/NCT01788488
NCT01788488CompletedNot Applicable

Impact of Measuring Serum Procalcitonin Levels on Duration of Antimicrobial Therapy in Critical Care Patients With Suspected Pneumonia

Mayo Clinic2 sites in 1 country134 target enrollmentStarted: February 2013Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
134
Locations
2
Primary Endpoint
Length of antibiotic therapy

Study Overview

Brief Summary

The goal of the study is to determine the impact of procalcitonin (PCT)-guided therapy on duration of antibiotic therapy in critical care unit (CCU) patients with suspected pneumonia at Mayo Clinic Health System Eau Claire.

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Length of antibiotic therapy

Time Frame: Indefinite

Participants will be followed for the entire time they are on antibiotics to treat pneumonia, an expected average of 30 total antibiotic days.

Secondary Outcomes

  • Length of stay in critical care unit(Indefinite)
  • Cost(Once)
  • Length of stay in the hospital(Indefinite)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Kent H. Gierhart

PI

Mayo Clinic

Study Sites (2)

Loading locations...

Similar Trials